PEN
Penumbra Inc
NYSE · Healthcare · Medical - Devices · US
$322.45
+0.76%Forward multiples
Based on analyst estimates
- P/E forward
- 55.47x
- P/E 2026E
- 69.35x
- P/E 2027E
- 54.35x
- P/E 2028E
- 46.60x
- P/S forward
- 7.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- 80.81x
- PEG TTM
- 1.77x
- Price / book
- 8.03x
- Price / sales
- 8.15x
- Price / cash flow
- 48.69x
Enterprise value
- Enterprise value
- $12.2B
- EV / sales
- 7.85x
- EV / EBITDA
- 53.42x
- EV / EBIT
- 64.70x
- Market cap
- $12.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026